Molecular complexity of intraductal carcinoma of the prostate

被引：3
作者：
Zhu, Sha [1 ]
Xu, Nanwei [1 ]
Zeng, Hao [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, Chengdu 610041, Peoples R China
来源：
CANCER MEDICINE | 2024年 / 13卷 / 02期
关键词：
DNA damage and repair; Intraductal carcinoma of the prostate; MED12; molecular characteristics; MYC; NCOR2; prostate acinar adenocarcinoma; PTEN; RB1; SChLAP1; targeted therapy; TMPRSS2-ERG fusion; TP53; GLEASON PATTERN 4; TMPRSS2-ERG GENE FUSION; PTEN GENOMIC DELETION; PSA RECURRENCE; INTRAEPITHELIAL NEOPLASIA; INVASIVE ADENOCARCINOMA; RADICAL PROSTATECTOMY; HISTOLOGIC FEATURES; ANALYTIC VALIDATION; MED12; MUTATIONS;
D O I：
10.1002/cam4.6939
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Intraductal carcinoma of the prostate (IDC-P) is an aggressive subtype of prostate cancer characterized by the growth of tumor cells within the prostate ducts. It is often found alongside invasive carcinoma and is associated with poor prognosis. Understanding the molecular mechanisms driving IDC-P is crucial for improved diagnosis, prognosis, and treatment strategies. This review summarizes the molecular characteristics of IDC-P and their prognostic indications, comparing them to conventional prostate acinar adenocarcinoma, to gain insights into its unique behavior and identify potential therapeutic targets.
引用
收藏
页数：10
相关论文
共 92 条
  • [61] The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
    Prensner, John R.
    Iyer, Matthew K.
    Sahu, Anirban
    Asangani, Irfan A.
    Cao, Qi
    Patel, Lalit
    Vergara, Ismael A.
    Davicioni, Elai
    Erho, Nicholas
    Ghadessi, Mercedeh
    Jenkins, Robert B.
    Triche, Timothy J.
    Malik, Rohit
    Bedenis, Rachel
    McGregor, Natalie
    Ma, Teng
    Chen, Wei
    Han, Sumin
    Jing, Xiaojun
    Cao, Xuhong
    Wang, Xiaoju
    Chandler, Benjamin
    Yan, Wei
    Siddiqui, Javed
    Kunju, Lakshmi P.
    Dhanasekaran, Saravana M.
    Pienta, Kenneth J.
    Feng, Felix Y.
    Chinnaiyan, Arul M.
    [J]. NATURE GENETICS, 2013, 45 (11) : 1392 - +
  • [62] Characterizing CDK12-Mutated Prostate Cancers
    Rescigno, Pasquale
    Gurel, Bora
    Pereira, Rita
    Crespo, Mateus
    Rekowski, Jan
    Rediti, Mattia
    Barrero, Maialen
    Mateo, Joaquin
    Bianchini, Diletta
    Messina, Carlo
    de la Maza, Maria D. Fenor
    Chandran, Khobe
    Carmichael, Juliet
    Guo, Christina
    Paschalis, Alec
    Sharp, Adam
    Seed, George
    Figueiredo, Ines
    Lambros, Maryou
    Miranda, Susana
    Ferreira, Ana
    Bertan, Claudia
    Riisnaes, Ruth
    Porta, Nuria
    Yuan, Wei
    Carreira, Suzanne
    de Bono, Johann S.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (02) : 566 - 574
  • [63] Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis
    Risbridger, Gail P.
    Taylor, Renea A.
    Clouston, David
    Sliwinski, Ania
    Thorne, Heather
    Hunter, Sally
    Li, Jason
    Mitchell, Gillian
    Murphy, Declan
    Frydenberg, Mark
    Pook, David
    Pedersen, John
    Toivanen, Roxanne
    Wang, Hong
    Papargiris, Melissa
    Lawrence, Mitchell G.
    Bolton, Damien M.
    [J]. EUROPEAN UROLOGY, 2015, 67 (03) : 496 - 503
  • [64] Intraductal Carcinoma of the Prostate
    Robinson, Brian
    Magi-Galluzzi, Cristina
    Zhou, Ming
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (04) : 418 - 425
  • [65] Robinson D, 2015, CELL, V161, P1215, DOI [10.1016/j.cell.2015.05.001, 10.1016/j.cell.2015.06.053]
  • [66] Med12 is essential for early mouse development and for canonical Wnt and Wnt/PCP signaling
    Rocha, Pedro P.
    Scholze, Manuela
    Bleiss, Wilfrid
    Schrewe, Heinrich
    [J]. DEVELOPMENT, 2010, 137 (16): : 2723 - 2731
  • [67] ERG expression in intraductal carcinoma of the prostate: comparison with adjacent invasive prostatic adenocarcinoma
    Schneider, Thomas M.
    Osunkoya, Adeboye O.
    [J]. MODERN PATHOLOGY, 2014, 27 (08) : 1174 - 1178
  • [68] PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma)
    Shah, Rajal B.
    Shore, Karen T.
    Yoon, Jiyoon
    Mendrinos, Savvas
    McKenney, Jesse K.
    Tian, Wei
    [J]. PROSTATE, 2019, 79 (11) : 1267 - 1273
  • [69] The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
    Sharma, Ankur
    Yeow, Wen-Shuz
    Ertel, Adam
    Coleman, Ilsa
    Clegg, Nigel
    Thangavel, Chellappagounder
    Morrissey, Colm
    Zhang, Xiaotun
    Comstock, Clay E. S.
    Witkiewicz, Agnieszka K.
    Gomella, Leonard
    Knudsen, Erik S.
    Nelson, Peter S.
    Knudsen, Karen E.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (12) : 4478 - 4492
  • [70] Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients
    Stoehr, Robert
    Taubert, Helge
    Gaisa, Nadine T.
    Smeets, Daniela
    Kneitz, Burkhard
    Giedl, Johannes
    Ruemmele, Petra
    Wieland, Wolf F.
    Rau, Tilman T.
    Hartmann, Arndt
    [J]. JOURNAL OF PATHOLOGY, 2013, 230 (04) : 453 - 456
12345678910